CNBT
PFE icon

Canandaigua National Bank & Trust’s Pfizer PFE Stock Holding History

Canandaigua National Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.86M Buy
+160,394
New +$4.2M 0.33% 65
2025
Q4 		$4.12M Sell
165,575
-24,564
-13% -$619K 0.37% 55
2025
Q3 		$4.84M Sell
190,139
-28,742
-13% -$709K 0.43% 50
2025
Q2 		$5.31M Buy
218,881
+29,392
+16% +$685K 0.49% 44
2025
Q1 		$4.8M Sell
189,489
-10,037
-5% -$263K 0.48% 46
2024
Q4 		$5.29M Sell
199,526
-35,751
-15% -$970K 0.52% 42
2024
Q3 		$6.81M Buy
235,277
+44,957
+24% +$1.31M 0.65% 37
2024
Q2 		$5.33M Sell
190,320
-858
-0.4% -$23.6K 0.58% 37
2024
Q1 		$5.31M Sell
191,178
-15,035
-7% -$417K 0.78% 32
2023
Q4 		$5.94M Sell
206,213
-60,871
-23% -$1.84M 0.92% 24
2023
Q3 		$8.86M Buy
267,084
+31,361
+13% +$1.11M 1.43% 15
2023
Q2 		$8.65M Buy
235,723
+28,293
+14% +$1.1M 1.4% 16
2023
Q1 		$8.46M Buy
+207,430
New +$8.96M 1.42% 14
2020
Q1 		$6.91M Sell
222,994
-9,599
-4% -$327K 1.46% 12
2019
Q4 		$8.65M Sell
232,593
-1,099
-0.5% -$39.1K 1.46% 11
2019
Q3 		$7.97M Buy
233,692
+5,767
+3% +$210K 1.41% 15
2019
Q2 		$9.37M Buy
227,925
+180
+0.1% +$7.15K 1.73% 9
2019
Q1 		$9.18M Buy
227,745
+2,211
+1% +$88.5K 1.76% 9
2018
Q4 		$9.34M Sell
225,534
-4,157
-2% -$173K 1.97% 8
2018
Q3 		$9.6M Buy
229,691
+2,932
+1% +$113K 1.71% 9
2018
Q2 		$7.8M Sell
226,759
-1,370
-0.6% -$46.8K 1.5% 11
2018
Q1 		$7.68M Buy
228,129
+53,090
+30% +$1.83M 0.98% 21
2017
Q4 		$6.01M Sell
175,039
-5,801
-3% -$198K 1.09% 23
2017
Q3 		$6.13M Buy
180,840
+11,561
+7% +$372K 1.17% 23
2017
Q2 		$5.39M Sell
169,279
-501
-0.3% -$15.8K 1.11% 22
2017
Q1 		$5.51M Sell
169,780
-12,085
-7% -$381K 1.63% 13
2016
Q4 		$5.6M Buy
181,865
+4,843
+3% +$148K 1.68% 13
2016
Q3 		$5.69M Buy
177,022
+2,241
+1% +$74.9K 1.64% 15
2016
Q2 		$5.84M Buy
174,781
+3,479
+2% +$111K 1.66% 15
2016
Q1 		$4.82M Buy
171,302
+8,397
+5% +$240K 1.41% 19
2015
Q4 		$4.99M Sell
162,905
-2,138
-1% -$67.3K 1.52% 13
2015
Q3 		$4.92M Buy
165,043
+2,504
+2% +$80.3K 1.58% 14
2015
Q2 		$5.17M Buy
162,539
+10,118
+7% +$330K 1.51% 14
2015
Q1 		$5.03M Buy
152,421
+8,991
+6% +$286K 1.51% 15
2014
Q4 		$4.24M Sell
143,430
-5,513
-4% -$158K 1.35% 16
2014
Q3 		$4.18M Sell
148,943
-1,694
-1% -$47.5K 1.39% 16
2014
Q2 		$4.24M Sell
150,637
-2,057
-1% -$58.6K 1.41% 17
2014
Q1 		$4.65M Buy
152,694
+14,336
+10% +$427K 1.57% 16
2013
Q4 		$4.02M Buy
138,358
+2,198
+2% +$64K 1.42% 17
2013
Q3 		$3.71M Sell
136,160
-1,070
-0.8% -$29.1K 1.41% 17
2013
Q2 		$3.65M Buy
+137,230
New +$3.79M 1.43% 17

Other funds holding PFE

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Canandaigua National Bank & Trust's PFE Position: Q2 2026 in Review

Canandaigua National Bank & Trust opened a new position in Pfizer (PFE) in Q2 2026: 160,394 shares worth $3.86M. The stake represents 0.33% of the portfolio and ranks #65 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in PFE as recently as Q4 2025.

Canandaigua National Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 41 quarters since. The position peaked at $9.6M in Q3 2018. 1,426 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Canandaigua National Bank & Trust held 160,394 shares of Pfizer worth $3.86M as of Q2 2026.
  • Pfizer was a new Canandaigua National Bank & Trust position in Q2 2026.
  • Pfizer made up 0.33% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #65 holding.
  • Canandaigua National Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 41 quarters since.
  • Canandaigua National Bank & Trust's Pfizer position peaked at $9.6M in Q3 2018.
  • 1,426 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.